Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26M Sell
116,533
-32,730
-22% -$7.41M 0.11% 183
2026
Q1
$25.2M Sell
149,263
-789
-0.5% -$138K 0.12% 151
2025
Q4
$24.5M Buy
150,052
+1,502
+1% +$226K 0.13% 149
2025
Q3
$20.1M Buy
148,550
+113,215
+320% +$16M 0.13% 151
2025
Q2
$4.58M Buy
35,335
+10,951
+45% +$1.28M 0.04% 388
2025
Q1
$2.98M Buy
24,384
+5,239
+27% +$675K 0.03% 422
2024
Q4
$2.21M Buy
19,145
+11,966
+167% +$1.72M 0.03% 469
2024
Q3
$1.08M Buy
7,179
+1,275
+22% +$192K 0.02% 547
2024
Q2
$933K Buy
5,904
+3,788
+179% +$658K 0.04% 372
2024
Q1
$419K Buy
2,116
+691
+48% +$126K 0.06% 305
2023
Q4
$248K Buy
+1,425
New +$226K 0.06% 241

Other funds holding NUE

&Partners's NUE Position: Q2 2026 in Review

&Partners reduced its Nucor (NUE) stake by 22% in Q2 2026, selling an estimated $7.41M and leaving 116,533 shares worth $26M. The position accounts for 0.11% of the portfolio, ranked #183.

&Partners first reported a position in NUE in Q4 2023 and has held it in 11 quarters since. 1,541 funds tracked by Wall St. Rank hold NUE as of Q2 2026.

  • &Partners held 116,533 shares of Nucor worth $26M as of Q2 2026.
  • &Partners sold 32,730 Nucor shares in Q2 2026, an estimated $7.41M.
  • Nucor made up 0.11% of &Partners's portfolio in Q2 2026, its #183 holding.
  • &Partners first reported a position in Nucor in Q4 2023 and has held it in 11 quarters since.
  • 1,541 funds tracked by Wall St. Rank held Nucor as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.